Anzeige
Mehr »
Samstag, 31.01.2026 - Börsentäglich über 12.000 News
Freitagabend nachbörslich veröffentlicht - was der Markt erst am Montag sieht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41FX4 | ISIN: US09076W3079 | Ticker-Symbol:
NASDAQ
30.01.26 | 21:59
1,140 US-Dollar
-2,15 % -0,025
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOAFFINITY TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
BIOAFFINITY TECHNOLOGIES INC 5-Tage-Chart

Aktueller Chart BIOAFFINITY TECHNOLOGIES Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
BIOAFFINITY TECHNOLOGIES INC-Investoren interessieren sich auch für diese Wertpapiere
Bristol-Myers Squibb Company: Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung CancerJoint initiative to focus on expanding early detection and equitable access to care through lung cancer specific AI workflows on Microsoft's suite of radiology solutionsOriginally published on BMS.com...
► Artikel lesen
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035BENGALURU, India, Jan. 20, 2026 /PRNewswire/ -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its...
► Artikel lesen
Bristol Myers Squibb Partners With Microsoft On AI Lung Cancer DetectionNEW YORK CITY (dpa-AFX) - Bristol Myers Squibb Co. (BMY), on Tuesday announced that it has entered into an agreement with Microsoft Corp. (MSFT) to accelerate the early detection of lung cancer...
► Artikel lesen
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent OfferingHERZLIYA, Israel and CALGARY, AB, Jan. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology...
► Artikel lesen
Innocan Pharma Corporation plant Listing an der NYSE American Stock Exchange mit gleichzeitigem EmissionsangebotHerzliya, Israel und Calgary, AB - 2. Januar 2026 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) (das "Unternehmen" oder "Innocan"), ein pharmazeutisches Technologieunternehmen...
► Artikel lesen
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent OfferingHERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company...
► Artikel lesen
Viatris Launches Inpefa To Treat Heart Failure In UAEWASHINGTON (dpa-AFX) - Viatris Inc. (VTRS), a healthcare company, Tuesday announced the launch of Inpefa or sotagliflozin in the United Arab Emirates or UAE, which is the first country within...
► Artikel lesen
Viatris Inc.: Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs OfficerPITTSBURGH, Jan. 8, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) announced today that Lara Ramsburg has been appointed Chief People and Corporate Affairs Officer. As part of Viatris'...
► Artikel lesen
Viatris To Sell Equity Stake In Biocon Biologics To Biocon For $815 MlnNEW DELHI (dpa-AFX) - Viatris Inc. (VTRS) announced that it has entered into definitive agreements with Biocon Limited for the sale of its equity stake in Biocon Biologics Limited. Under the...
► Artikel lesen